BN Business News
Add your company to Business Communicator →

Business · 27/03/2014Updated: 10/17/2026 · 1 min read

AbbVie Inc., et al. Propose Withdrawal of Approval for Prescription Pain Medications Containing High Levels of Acetaminophen

Summary

The FDA is seeking public input on a proposal to withdraw approval of certain prescription pain medications containing more than 325 milligrams of acetaminophen, citing concerns over liver safety risks.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →